Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy. - Schwarz M; Schwarz C; Schütz A; Schwanke C; Krabb E; Schubert R; Liebich ST; Bauer D; Burghart L; Brinkmann L; Gutic E; Reiberger T; et al. (Journal of virus eradication, 2023)